Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.3K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.6K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Riding toward Selectivity: Optimization of Covalent 7-Azaindole-Based BMX Kinase Inhibitors.

Journal of medicinal chemistry·2026
Same author

CDCR-Rank: a computational model for predicting drug combination dose response using ranking-based optimization.

Bioinformatics advances·2026
Same author

MT-ConBiFormer-GPT: multi-target molecular generation for low-data drug discovery via a contrastive BiFormer-GPT architecture and curriculum learning with cross-domain generalization.

Briefings in bioinformatics·2026
Same author

DeepDRP: Dose-response predictions of drug pairs using deep learning based on data-driven feature representation and dose-response curve characteristics.

PloS one·2026
Same author

Detection of Pediatric Dental Caries in Panoramic Radiograph Using Deep Learning: A Benchmark Study on MD-OPG.

Sensors (Basel, Switzerland)·2026
Same author

Multi-DDA: drug-disease association prediction using a hybrid graph convolutional network with multi-modal drug representations.

Bioinformatics advances·2026

Related Experiment Video

Updated: Dec 9, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.4K

Deep Learning in Drug Target Interaction Prediction: Current and Future Perspectives.

Karim Abbasi1, Parvin Razzaghi2, Antti Poso3

  • 1Laboratory of Systems Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran 1417614411, Iran.

Current Medicinal Chemistry
|September 8, 2020
PubMed
Summary

This study overviews deep learning for drug-target interactions (DTIs) prediction, a crucial step in drug discovery. It analyzes deep network architectures, feature extraction, and datasets to guide future computational approaches.

Keywords:
DTIs prediction approachesDeep learningDrug discoveryDrug-target interaction predictionEC50Machine learning

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

910

Related Experiment Videos

Last Updated: Dec 9, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.4K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.3K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

910

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Machine learning in drug discovery

Background:

  • Drug-target interactions (DTIs) prediction is vital for efficient drug discovery.
  • Experimental methods for DTIs are resource-intensive; computational approaches offer an alternative.
  • Machine learning, particularly deep learning, shows significant promise for DTI prediction.

Purpose of the Study:

  • To provide a comprehensive review of deep learning-based methods for DTI prediction.
  • To analyze various deep network architectures used for feature extraction from drug and protein sequences.
  • To compare the advantages and limitations of different DTI prediction approaches.

Main Methods:

  • Systematic investigation of existing deep learning models for DTI prediction.
  • Analysis of feature extraction techniques using deep neural networks on drug compounds and protein sequences.
  • Exploration of feature descriptor combination strategies and commonly used DTI datasets.

Main Results:

  • Identified and compared diverse deep network architectures employed in DTI prediction.
  • Evaluated methods for integrating drug and protein features.
  • Cataloged prevalent datasets utilized in the field.

Conclusions:

  • Deep learning offers powerful tools for advancing DTI prediction in drug discovery.
  • Understanding architectural choices and feature representations is key to improving prediction accuracy.
  • Further research is needed to address current challenges and explore future directions in deep learning for DTI prediction.